Pharmabiz

Cordis unveils positive results from SELUTION DeNovo and SELUTION4ISR randomized trials at TCT 2025

Cordis unveils positive results from SELUTION DeNovo and SELUTION4ISR randomized trials at TCT 2025: Our Bureau, Mumbai ...
Pharmabiz

Gilead’s Livdelzi demonstrates sustained efficacy in PBC, offering ALP reduction, itch relief and potential to slow disease progression

Gilead’s Livdelzi demonstrates sustained efficacy in PBC, offering ALP reduction, itch relief and potential to slow disease progression: Foster City, California Monday, November ...
Pharmabiz

Cyber crime involving Rs. 2.16 crore as fraudsters intercept emails between Group Pharmaceuticals and Dr Reddy's Labs

Cyber crime involving Rs. 2.16 crore as fraudsters intercept emails between Group Pharmaceuticals and Dr Reddy's Labs: Our Bureau, Bengaluru Monday, November 10, 2025, 17:15 Hrs [ ...
Pharmabiz

HBA 2025 India Leadership Summit in Mumbai discusses talent development in healthcare and pharma

HBA 2025 India Leadership Summit in Mumbai discusses talent development in healthcare and pharma: Our Bureau, Mumbai Monday, November 10, 2025, 17:30 Hrs [IST] The Healthcare Busi ...
Pharmabiz

US FDA approves Darzalex Faspro for adult patients with high-risk smouldering multiple myeloma

US FDA approves Darzalex Faspro for adult patients with high-risk smouldering multiple myeloma: San Diego Monday, November 10, 2025, 17:00 Hrs [IST] Halozyme Therapeutics, Inc. (H ...
Pharmabiz

Gilead announces phase 3 ASCENT-07 study of Trodelvy versus chemotherapy to treat post-endocrine therapy in HR+/HER2-negative metastatic breast cancer fails to meet the primary ...

Gilead announces phase 3 ASCENT-07 study of Trodelvy versus chemotherapy to treat post-endocrine therapy in HR+/HER2-negative metastatic breast cancer fails to meet the primary en ...
Pharmabiz

New research finds women with early-stage breast cancer can avoid radiotherapy after mastectomy

Women with early-stage breast cancer can avoid radiotherapy after mastectomy as it does not affect long-term survival, new research finds. An international trial found that patients with early-stage ...
Pharmabiz

Takeda presents new data showing mezagitamab sustained effect on kidney function 18 months after treatment in primary IgA nephropathy

Takeda presents new data showing mezagitamab sustained effect on kidney function 18 months after treatment in primary IgA nephropathy: Osaka, Japan Monday, November 10, 2025, 15:0 ...
Pharmabiz

Organon to divest its JADA System for up to $465 million to Laborie Medical Technologies

Organon to divest its JADA System for up to $465 million to Laborie Medical Technologies: Jersey City, New Jersey Monday, November 10, 2025, 14:00 Hrs [IST] Organon, a global heal ...
Pharmabiz

Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India as a second brand of Wegovy

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...
Pharmabiz

TG-PackCON 2025 highlighted Telangana’s four-pronged strategy for growth in life sciences

TG-PackCON 2025 highlighted Telangana’s four-pronged strategy for growth in life sciences. The event laid a strong roadmap for India’s pharmaceutical, medical devices, biotech and AI-driven health ...
Pharmabiz

Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis

Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...